German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...

On Wednesday, Merck & Co Inc (MRK) stock saw a decline, ending the day at $110.42 which represents a decrease of $-1.11 or -1.00% from the prior close of $111.53. The stock opened at $111 and touched ...

Furthermore, Merck will sponsor and fund one of the RCC phase 3 studies, while Exelixis will co-fund the phase 1/2 trial and the other phase 3 study, also supplying zanzalintinib and cabozantinib.

In this article, we will look at where Merck & Co. Inc. (NYSE:MRK) ranks among the most undervalued quality stocks to buy according to analysts. Are More Rate Cuts Necessary to Maintain The ...

In 2018, Merck is determined to step up for patients. Patient centricity constitutes one of the priorities for the company’s two-year mandate of the Presidency of the European Federation of ...

Deutsche Bank has adjusted its price target for Merck KGaA (MRK ... The modification comes with anticipations that the company will reaffirm its 2024 guidance despite potential slight ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Reid said the late George Purvis, longtime Game and Fish information chief, created the retro logo in the late 1960s. It ...

Societe Generale has recently reduced Merck & Co Inc (MRK) stock to Sell rating, as announced on March 11, 2024, according to Finviz. Earlier, on January 4, 2024, TD Cowen had raised the stock from a ...

Mtn Dew” is getting a makeover, with the word “mountain” reappearing on cans and bottles following a roughly two-decade-long ...

Merck & Co has joined with the non-profit scientific research organisation, the International AIDS Vaccine Initiative (IAVI), to develop a potential vaccine against the SARS-CoV-2 coronavirus that ...